BCPEM
MDCO

Bain Capital Public Equity Management’s Medicines Co MDCO Stock Holding History

Bain Capital Public Equity Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-52,807
Closed -$1.94M – 86
2018
Q2 		$1.94M Sell
52,807
-3,697
-7% -$120K 0.13% 53
2018
Q1 		$1.86M Buy
+56,504
New +$1.77M 0.14% 51

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bain Capital Public Equity Management's MDCO Position: Q3 2018 in Review

Bain Capital Public Equity Management sold out of Medicines Co (MDCO) in Q3 2018, closing a stake of 52,807 shares — an estimated $1.94M sold.

Bain Capital Public Equity Management first reported a position in MDCO in Q1 2018 and held it in 2 quarters. The position peaked at $1.94M in Q2 2018. 184 funds tracked by Wall St. Rank hold MDCO as of Q3 2018.

  • Bain Capital Public Equity Management reported no remaining Medicines Co position as of Q3 2018 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 52,807 Medicines Co shares in Q3 2018, an estimated $1.94M.
  • Bain Capital Public Equity Management first reported a position in Medicines Co in Q1 2018 and held it in 2 quarters.
  • Bain Capital Public Equity Management's Medicines Co position peaked at $1.94M in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q3 2018.

Based on Bain Capital Public Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.